When PD-1 on Teffs is combined with PD-L1 expressed on tumor cells, the process will initiate the programmed cell death of T cells, thus tumor cells attack the anti-tumor immune response of activated T cells, achieving immune evasion. This evidence concerns the gene PDCD1 and neoplasm.